Eli Lilly Could Become The World’s Top AI Firm? Jordi Visser Has Reasons To Believe Mounjaro Maker Could
Speaking on “The Pomp Podcast” with crypto investor and entrepreneur Anthony Pompliano Saturday, Visser said Eli Lilly’s more…
Novo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake – Eli Lilly (NYSE:LLY)
Early Prescription Trends Show Slower Start For Lilly Reuters, citing IQVIA data, reported that Eli Lilly recorded 1,390…
AI Bubble Fear? This Sector Is Quietly Surging While Tech Sinks – Amgen (NASDAQ:AMGN), Bristol-Myers Squibb (NYSE:BMY)
It hasn’t been an easy stretch for technology and AI stocks, with triple-digit year-to-date gainers like Palantir Technologies…
Trump-Pfizer Deal Pushes Health Care To Best Rally In 5 Years – Agilent Technologies (NYSE:A), Biogen (NASDAQ:BIIB)
Investors cheered a breakthrough drug pricing agreement between President Donald Trump and Pfizer Inc. (NYSE:PFE), sparking a sector-wide…
Eli Lilly’s Orforglipron Data Is Not Disastrous: Analyst – Eli Lilly (NYSE:LLY)
Eli Lilly and Co LLY released underwhelming data from a Phase 3 ATTAIN-1 trial evaluating orforglipron, an investigational…